Integrative Diagnosis for SCD and Other RADs
Integrative Diagnosis of Sickle Cell Disease (SCD) and Other Rare Anemia Disorders (RADs) for Personalized Medicine
Phase
Not reported
Enrollment
200 (est.)
Age range
— to —
Sex
ALL
Summary
INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and genetic characterization through combining new generation methodologies.
Conditions studied
Sign-up window
Nov 13, 2020 – est. completion May 25, 2025
Sponsors
Study locations
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona
Hospital Sant Joan de Déu
Esplugues de Llobregat, Barcelona
Hospital General de Granollers
Granollers, Barcelona
Consorci Sanitari del Maresme - Hospital de Mataró
Mataró, Barcelona
Parc Taulí Hospital Universitari
Sabadell, Barcelona
Hospital Universitari Mútua de Terrassa
Terrassa, Barcelona
Consorci Sanitari de Terrassa
Terrassa, Barcelona
Hospital Universitari Arnau de Vilanova
Lleida, Lleida